Production of recombinant drugs and human vaccines
Production of medicine with Persis Gene brand
Contract production for CMOs
Accelerator and Technology Services (CRO)
Technology design and development
Technical Knowledge Transfer and Scale Up
Writing a medication file
Technology startups usually need specialized laboratory and infrastructure equipment to work on their idea.
In most cases, market is not available for technology startups and serious measures need to be taken for access to market.
Technology startups are less attractive for non-specialized investors due to difficult and time-consuming access to technology as compared to service startups.
The common acceleration pattern such as funding event, Seed Money, receiving stock and … are not necessarily suitable for technology accelerator.
Status of Present Groups in Accelerator
Examples of Persis Gene Accelerator
Outgoing Companies
Projects
Monoclonal Antibody
Human Serum
Human Vaccine
Recombinant Proteins
Plasma drived product
Animal Vaccines
PersisGen Accelerator Future Programs
Expertise Diversification
Launching stem cells accelerator of PersisGen in Kharazmi University with a focus on stem cells technologies
Brand Awareness
Defining technology accelerator for the audience out of biotechnology industry; raising awareness about nature of accelerator for audience in the pharmaceuticals and biotechnology industry
Geographical Development
Developing PersisGen business model and launching PersisGen branch offices in Shiraz, Tabriz and Urmia in order to reconnoiter experts from various parts of Iran in the biopharmaceuticals field.
Features of Biopharmaceutical Industry
Manufacturing Countries
A few countries have ventured production of biological medicines due to patent issues and its knowledge/capital intensive nature.
Target Community
Biological medicines are basically produced for special and refractory diseases such as cancer and autoimmune disease.
Investment
It has a long term of output and requires a high investment volume.
Complexity
Manufacturing biological medicines is a highly technical complicated process.
Security and Independence
Country’s pharmaceutical security in the field of biological medicines is of high importance (in terms of cost and access).
Production and Consumption Conditions
Biological medicines must be administered by injection and stored refrigerated.
Term of Production
Clinical trial period is minimum 1.5 to 2 years and course of production is at least 5 years for biological medicines.
Employment of Educated Individuals
Manufacturing biological medicines is featured by high rate of educated people employment.
PersisGen Available Services
The technology team supplies consumables in addition to knowledge and manpower.
Not receiving stock from technology teams to protect freedom of operation, and at the same time, non provision of seed money.
Infrastructural facilities, including physical space, lab, human resource, mentorship, technical training and general business training, and the last but not least, commitment to sell resulted technology
Conducting training courses on business establishment and governance as well as administrative support including company’s registration, obtaining commercial card, assisting access to knowledge-based certificate and … through companies providing commercialization services.
The venue for receiving loan and/or concluding VC agreement with a preferable interest rate through biotechnology development headquarters
The pre-acceleration period is 2-4 months and the acceleration period is 15-20 months for technology teams
PersisGen Accelerator Distinctive Features
Distinctive Business Model
Not receiving stock of technology companies during acceleration period of income generation from providing technical services and soliciting outsourced projects
Diversity in Partnership Models
Adoption of diverse models of partnership for different beneficiaries such as technology teams, investors, production companies, companies that need services and …
Technology-based Accelerator
Focus on specialized startups acceleration in the field of biotechnologies and stem cells and substantive distinction and difference with accelerators in service and IT domains
Corporate Venture Capital
Supply of infrastructure required by admitted technology startups and solicit investor and guarantee investment for technologies made by technology teams
Deep understanding of both sides of supply and demand (technology and market)
Analysis of real needs of industry, government and market and analysis of imported biomedicines as priorities of admitting technology teams
Achievements of Iranian Pharmaceutical Biotechnology Industry
2
rank
in production of biopharmaceuticals in Asia after Japan
950
million Dollar
annual currency saving as a result of manufacturing biopharmaceuticals locally
4000
employment opportunities
Employment of the most educated manpower in biopharmaceutical industry
7
biopharmaceutical manufacturer
companies (CinaGene, Aryogen, Pooyesh Darou and …)
22
Drugs
Locally manufactured biopharmaceuticals (some are among the first top 10 best-selling biomedicines)
40
percent
Share of biopharmaceuticals from total export of medicines (60 million from 150 million Dollar)
PersisGen Accelerator Major Objectives
Manpower
Recruiting young educated manpower and creating job opportunities based on merits according to annual evaluations
Export
Entering international markets through export and transfer of know-how based on standards of destination countries 2 years after product is introduced to the domestic market
Market Share
Maximum market share locally based on clinical trials and scientific/ theoretical methods; so as to the market share will be 20% in the initial year, increasing up to 70% within 3 years time.
Quality and Safely
High quality and safety of products, taking advantage of the modern manufacturing process of biotechnological medicines based on the latest world standards
Manufacturing
Manufacturing biological medicines based on recombinant proteins and monoclonal antibodies, totally unprecedented in the country
PersisGen Organizational Values
Creativity and Innovation
Creation, presentation and implementation of new ideas in the context of improving organizational performance
Trust and Honesty
Transparency and good will towards others and building trust through conformity of thoughts, words and deeds
Respect and Dignity
Recognizing and taking into serious account of rights of others and honoring human dignity
Commitment and Accountability
Being accountable for decisions made and entrusted duties together with loyalty and compassion
Knowledge based teams and Startups in PersisGen
TOP 13 Team in PersisGen Accelerator
Certificates
PersisGen Contact Info.
No. 125, 22nd km of Tehran-Karaj Makhsous road, Tehran, Iran.
+98 (21) 46074876
+98 (21) 46074876
info@persisgen.com
Share your comments and opinion with us
PersisGen Par welcomes any suggestion and/or criticism for improvement of facilities and better quality of provided services; so please send us your comments through the available form.
We’ll Contact you as soon as possible.